1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Apathy and affective symptoms associated with elevated plasma neurofilament light but not p-tau181 in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Blood-based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings : A systematic review and meta-analysis
- Contribution to journal › Scientific review
-
Mark
Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings
- Contribution to journal › Article
-
Mark
How can Alzheimer's disease blood-based biomarkers reach clinical practice?
- Contribution to journal › Article
-
Mark
Influence of ethnicity on the diagnostic accuracy of plasma p-tau217 for the identification of Alzheimer's disease : A consecutive mixed memory clinic cohort study
- Contribution to journal › Article
- 2024
-
Mark
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease
- Contribution to journal › Article
-
Mark
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease
- Contribution to journal › Article
-
Mark
Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Rationale and design of the BeyeOMARKER study : prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic
- Contribution to journal › Article
-
Mark
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217
- Contribution to journal › Article
